Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001641172-25-006036
Filing Date
2025-04-24
Accepted
2025-04-24 17:11:33
Documents
7
Effectiveness Date
2025-04-24

Document Format Files

Seq Description Document Type Size
1 forms-1mef.htm S-1MEF 62819
2 ex5-1.htm EX-5.1 19207
3 ex5-2.htm EX-5.2 17291
4 ex23-1.htm EX-23.1 4636
5 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 29411
6 ex5-2_001.jpg GRAPHIC 5753
7 ex5-1_001.jpg GRAPHIC 3326
  Complete submission text file 0001641172-25-006036.txt   147305
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: S-1MEF | Act: 33 | File No.: 333-286735 | Film No.: 25868867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)